VXL is the volume leader on TSX-V today on the news of Coronavirus vaccine patent application.
+21.74% so far. Likely held down by warrant sellers but could be a serious runner once they are out.
$12M mkt cap is cheap compared to other biomed stocks that ran on Coronavirus related news.
Very decent float at 89M shares.
